Cardiovascular Pharmacology: Open Access

Current Issue

Volume 11, Issue 12, 2022

Short Communication

Heartman: A Mobile Personal Health System for Heart Failure

• Laura Boeing*

DOI: 10.35248/2329-6607.22.11.317

Perspective

Characteristics of Heart Failure with Reduced and Preserved Ejection Fraction

• Barry Marria*

DOI: 10.35248/2329-6607.22.11.318

Commentary

Coronary Heart Disease: A Transient Ischemic Stroke

• Mehta Cobble*

DOI: 10.35248/2329-6607.22.11.319

Commentary

E-Cigarettes: Effects and Cardiovascular Dysfunction

• Francesco Thomas*

DOI: 10.35248/2329-6607.22.11.321

Opinion Article

Epidemiology Associated Coronary Heart Disease

• Downer Sarah*

DOI: 10.35248/2329-6607.22.11.320

Volume 12, Issue 1, 2023

Commentary

General Outlook on Causes and Consequences of Pericarditis

• Carla Lisa*

DOI: 10.35248/2329-6607.23.12.326

Opinion Article

Symptoms and Significance of Heart Failure

• Virginia Austen*

DOI: 10.35248/2329-6607.23.12.323

Commentary

Cardiopulmonary Resuscitation: Immediate Cardiac Arrest Survival Rate

• Stevens Benn*

DOI: 10.35248/2329-6607.23.12.322

Short Communication

Effects of the Coranary Artery Disease and its Functions

• Josef Lelasi*

DOI: 10.35248/2329-6607.23.12.331

Perspective

A General Perspective on the Cardiac Cycle

• Casper Rocha*

DOI: 10.35248/2329-6607.23.12.325

Perspective

Causes of Death in Congenital Heart Disease and Neurohumoral Activation in Adults

• Williams Jason*

DOI: 10.35248/2329-6607.23.12.328

Short Communication

Cardiopulmonary Arrest during the Perihemodialytic Process

• Durstine Larry*

DOI: 10.35248/2329-6607.23.12.331

Commentary Article

Clinical Trials of Refractory Angina and Cardiovascular Cell Therapy

• Hong Jian*

DOI: 10.35248/2329-6607.23.12.327

Opinion Article

Maternal Cardiac Arrest and Physiological Changes in Pregnant Woman

• Eishin Tanaka*

DOI: 10.35248/2329-6607.23.12.329

Perspective

Cardiovascular Disease Diagnosis and Positive Effect of Cardiokines

• Phillip Cosh*

DOI: 10.35248/2329-6607.23.12.330

Volume 12, Issue 2, 2023

Commentary

Identification, Causes, and Treatment of High Blood Pressure

• Daniel Sultzer*

DOI: 10.35248/2329-6607.23.12.333

Perspective

Variations in Biochemical Markers in Vascular Disorders and Its Identifications

• Mutch Karen*

DOI: 10.35248/2329-6607.23.12.336

Commentary

Thermodynamic Analysis of Cardiovascular System in Human Body

• Garland Najaman*

DOI: 10.35248/2329-6607.23.12.338

Commentary

Cardiovascular Disease Risk in Women with Chronic Rheumatic Diseases

• Cristian Stefan*

DOI: 10.35248/2329-6607.23.12.342

Commentary

Hypertension as a Significant Risk Factor in Coronary Heart Diseases (CHDs)

• Morris Dom*

DOI: 10.35248/2329-6607.23.12.340

Opinion Article

Statins: A Lipid-Lowering Medication to Prevent Cardiovascular Diseases (CVDs)

• Rand Ayn*

DOI: 10.35248/2329-6607.23.12.339

Brief Commentary

RAAS Inhibitors for the Treatment of Rheumatic Heart Disease

• Jouven Xavier*

DOI: 10.35248/2329-6607.23.12.341

Short Communication

General Perspective of Intravascular Photoacoustic Imaging (IVPA) and Intravascular Ultrasound (IVUS)

• Krista van Soest*

DOI: 10.35248/2329-6607.23.12.334

Perspective

Pulmonary Hypertension (PH) Related to Chronic Obstructive Pulmonary Disease (COPD): An Overview

• Joanne Bogaard*

DOI: 10.35248/2329-6607.23.12.335

Commentary

Identification of Congestive Heart Failure by Heart Rate Variability

• Markham Rebecca*

DOI: 10.35248/2329-6607.23.12.337

Volume 13, Issue 1, 2024

Short Communication

Advances in Anticoagulant Therapy: Optimizing Efficacy and Safety in Cardiovascular Patients

• Natsuo Murata*

DOI: 10.35248/2329-6607.24.13.380

Perspective

Innovative Pharmacological Techniques for the Treatment of Heart Failure

• Glenn Fahey*

DOI: 10.35248/2329-6607.24.13.383

Opinion Article

Benefits of Early Identification for Rheumatic Valvular Heart Disease

• Watkins Chang*

DOI: 10.35248/2329-6607.24.13.384

Opinion Article

Exploring the Latest Advances in Clinical Outcomes for Congestive Heart Failure Patients

• Keith Odom*

DOI: 10.35248/2329-6607.24.13.385

Opinion

Impact of Pharmacogenomics on Personalized Medicine in Cardiovascular Pharmacotherapy

• Chen Jain*

DOI: 10.35248/2329-6607.24.13.386

Perspective

Pharmacological Modulation of Lipid Metabolism: Implications for Cardiovascular Health

• Sunge Zin*

DOI: 10.35248/2329-6607.24.13.387

Opinion Article

Antiplatelet Medication for the Prevention of Heart Issues: Current and Forthcoming Activities

• Saul Gaddis*

DOI: 10.35248/2329-6607.24.13.388

Commentary

Pharmacological Interventions to Combat Thrombosis in Cardiovascular Disorders

• Peter Keneally*

DOI: 10.35248/2329-6607.24.13.389

Commentary

Balancing Safety and Efficacy in Antiarrhythmic Drug Therapy Advances

• Jia Feng*

DOI: 10.35248/2329-6607.24.13.381

Perspective Article

Challenges and Opportunities of Single-Cell Transcriptomics in Cardiac Arrest: Exploring Obstacles and Potential Benefits

• Callaway Weissman*

DOI: 10.35248/2329-6607.24.13.382

Volume 13, Issue 3, 2024

Commentary

A Scientific Analysis of Ayurveda in Restrictive Cardiomyopathy

• Amelia Emma*

DOI: 10.35248/2329-6607.24.13.400

Commentary

Cardiac Pharmacological Aspects Involved in Fabry Disease

• James Carter*

DOI: 10.35248/2329-6607.24.13.401

Commentary

The Evolution and Impact of Echocardiography in Cardiovascular Care in China

• Sophia Turner*

DOI: 10.35248/2329-6607.24.13.402

Short Communication

Immunological Aspects Involved in Brugada Syndrome

• Liam Anderson*

DOI: 10.35248/2329-6607.24.13.403

Perspective

Advances in Non-Valvular Atrial Fibrillation: From Epidemiology to Personalized Treatment Strategies

• Emily Wong*

DOI: 10.35248/2329-6607.24.13.404

Perspective

Pharmacological Interventions in Restrictive Cardiomyopathy: Historical and Scientific Perspectives

• Noah Patel*

DOI: 10.35248/2329-6607.24.13.405

Perspective

The Evolution of Valve-Sparing Root Replacement in Aortic Valve Disease

• Charlotte Müller*

DOI: 10.35248/2329-6607.24.13.406

Opinion Article

Spontaneous Coronary Artery Dissection: Diagnosis and Pharmacological Management

• William Tanaka*

DOI: 10.35248/2329-6607.24.13.407

Opinion Article

Long QT Syndrome: Genetics, Treatments and Patient-Centered Care

• Olivia Ndlovu*

DOI: 10.35248/2329-6607.24.13.408

Opinion Article

The Role of Dobutamine in Heart Failure and Cardiogenic Shock: Benefits, Risks and Future Directions

• Benjamin Silva*

DOI: 10.35248/2329-6607.24.13.409

Volume 13, Issue 4, 2024

Opinion Article

Role of Cardiovascular Drugs in Preventing and Treating Heart-Related Disorders

• Shaun Williams*

DOI: 10.35248/2329-6607.24.13.410

Commentary

Advances in Heart Failure Care: A Multidisciplinary Approach to Treatment and Prevention

• Nelson John*

DOI: 10.35248/2329-6607.24.13.411

Short Communication

Pharmacological Interventions for Pediatric Heart Diseases: Insights and Innovations

• Richard Wilson*

DOI: 10.35248/2329-6607.24.13.412

Perspective

Nanotechnology-Driven Advances in Cardiovascular Disease Treatment and Diagnosis

• Laura Jain*

DOI: 10.35248/2329-6607.24.13.413

Perspective

Nutraceuticals as Adjunct Therapy for Cardiovascular Disease: Mechanisms and Clinical Insights

• Evelyn Matthew*

DOI: 10.35248/2329-6607.24.13.414

Volume 14, Issue 1, 2025

Commentary

Colchicine in Cardiovascular Therapy: Evidence, Mechanisms and Emerging Applications

• Nathaniel Cruz*

DOI: 10.35248/2329-6607.25.14.415

Opinion Article

Cost Coverage and Care in the Socioeconomic Divide in Cardiometabolic Treatments

• Lina Moretti*

DOI: 10.35248/2329-6607.25.14.416

Perspective

Targeting MFAP4 for Advancing Retinal Neovascular Disease Therapies

• Hiroshi Yamamoto*

DOI: 10.35248/2329-6607.25.14.417

Short Communication

Advancing Cardiovascular Implants through FDM: Personalized Prostheses with Controlled Drug Release

• Thomas Muller*

DOI: 10.35248/2329-6607.25.14.418

Commentary

Impact of Chronic Antihypertensive Use on Aneurysmal Subarachnoid Hemorrhage Recovery

• Ekaterina Mikhailova*

DOI: 10.35248/2329-6607.25.14.419

Opinion Article

Optimizing Antiarrhythmic Drug Surveillance for Atrial Arrhythmias in Hospital Settings

• Jason Lee*

DOI: 10.35248/2329-6607.25.14.420

Perspective

Optimizing Medication Titration in Pediatric Heart Failure for Improved Outcomes

• Pauline Dubois*

DOI: 10.35248/2329-6607.25.14.421

Commentary

Advances in Targeted Antithrombotic Therapy for Safer Thrombosis Management

• Maria Popescu*

DOI: 10.35248/2329-6607.25.14.422

Opinion Article

Structural and Molecular Ambiguity in AV Nodal Dual Pathways

• Richard Evans*

DOI: 10.35248/2329-6607.25.14.423

Perspective

Pharmacokinetics and Cardiovascular Effects of Tramadol in Large Animal Neurosurgery

• Sofia Dimitriou*

DOI: 10.35248/2329-6607.25.14.424